Developing new methods to create important chemical bonds for pharmaceuticals
Harnessing Electrophilic N-Aryl Catalytic Intermediates for Versatile C-N Bond Formation
This study is exploring new ways to create important chemical bonds that can help make better medicines, which could lead to more effective treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10651848 on NIH RePORTER |
What this research studies
This research focuses on creating new chemical reactions that allow for the efficient formation of C–NHAr, C–C, and C–O bonds, which are essential in the development of pharmaceuticals and other materials that enhance human health. By utilizing unique nitrogen-based intermediates, the research aims to overcome existing challenges in organic synthesis that limit access to complex N-heterocyclic compounds. Patients may benefit from advancements in drug development that arise from these new synthetic methods, potentially leading to more effective treatments.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with conditions that could be treated by new drugs developed from these chemical advancements.
Not a fit: Patients who are not affected by conditions treatable with new pharmaceuticals may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new pharmaceuticals that improve patient health and quality of life.
How similar studies have performed: While the approach is innovative, similar research has shown promise in developing new synthetic methods that enhance drug discovery.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Driver, Tom G — University of Illinois at Chicago
- Study coordinator: Driver, Tom G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.